Global Leading Market Research Publisher QYResearch announces the release of its latest report “Skim Colostrum Powder – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Skim Colostrum Powder market, including market size, share, demand, industry development status, and forecasts for the next few years.
For health supplement manufacturers, functional food developers, and immune support formulators, bovine colostrum offers a rich source of immunoglobulins (IgG), growth factors, and antimicrobial peptides. However, whole colostrum powder contains high fat content (15-25%), limiting application in low-fat products and reducing shelf stability. The skim colostrum powder market addresses this through low-fat nutraceutical processing: removal of most fat content via skimming or centrifugation, retaining bioactive components while reducing fat to <5%, enabling use in health supplements and functional foods where low-fat content is desired. According to QYResearch’s updated model, the global market for Skim Colostrum Powder was estimated to be worth US$ 733 million in 2025 and is projected to reach US$ 1,019 million, growing at a CAGR of 4.9% from 2026 to 2032. In 2024, global sales of Skim Colostrum Powder reached approximately 18,000 tons, with an average of USD 40/kg. Skim Colostrum Powder is a colostrum-derived powder that has had most of its fat content removed through a skimming process. It retains the key bioactive components such as immunoglobulins, growth factors, and antimicrobial peptides, but with lower fat content. Skim colostrum powder is commonly used in health supplements and functional foods where low-fat content is desired, while still providing immune and nutritional benefits.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6094750/skim-colostrum-powder
1. Product Segmentation by IgG Content
Skim colostrum powder is segmented by immunoglobulin G (IgG) concentration, the primary bioactive marker for immune support efficacy:
| Segment | IgG Content | Typical Applications | Price (USD/kg) | Market Share (2025) | Key Characteristics |
|---|---|---|---|---|---|
| Standard | 30% | General immune support supplements, protein powders | $30-40 | 40% | Lowest cost, mass market |
| Premium | 30-40% | Clinical nutrition, sports recovery, elderly supplements | $40-60 | 45% | Best value for efficacy |
| Ultra-High | >40% | Medical foods, hospital tube feeding, veterinary | $60-100+ | 15% | Highest bioactivity, niche |
Key technical challenge – IgG preservation during processing: Heat and shear during skimming, pasteurization, and spray drying can denature immunoglobulins. Over the past six months, several advancements have emerged:
- Biostrum Nutraceutical (February 2026) introduced a “low-temperature” spray drying process (inlet 160°C → 140°C) with extended drying time, increasing IgG retention from 75% to 90% compared to standard spray drying.
- Colostrum BioTec (March 2026) commercialized a microfiltration-based skimming process (vs. centrifugal separation), which removes fat without mechanical shear, preserving growth factor activity (IGF-1, TGF-β) by 95% (vs. 80% for centrifugation).
- Immuno-Dynamic (January 2026) launched a “cold-processed” skim colostrum powder using freeze-drying (lyophilization) instead of spray drying, achieving 98% IgG retention but at 3x higher cost ($120/kg), targeting ultra-premium clinical applications.
Industry insight – manufacturing process: Skim colostrum powder production: raw colostrum collection (first 24-48 hours post-calving), fat separation (centrifugation or microfiltration), pasteurization (low-temperature, 63°C for 30 minutes or 72°C for 15 seconds HTST), concentration (evaporation), and drying (spray drying dominant, freeze-drying for premium). 18,000 tons annual production = approx. 180,000 tons raw colostrum (10:1 concentration ratio). Seasonality: calving seasons (spring/fall in Northern Hemisphere) affect raw material availability.
2. Market Segmentation: IgG Level and Application
The Skim Colostrum Powder market is segmented as below:
Key Players: Biostrum Nutraceutical, Immuno-Dynamic, Colostrum BioTec, BioNatIn, Powerstrum Colostrum
Segment by Type (IgG Content):
- <30% IgG – 40% of revenue. Mass market supplements, pet food, animal feed.
- 30-40% IgG – Largest segment (45% of revenue). Sports nutrition, immune support, gut health.
- >40% IgG – 15% of revenue. Medical foods, clinical nutrition, veterinary critical care.
Segment by Application:
- Retailing – Largest segment (65% of revenue). Dietary supplements (capsules, tablets, powders) sold through health food stores, pharmacies, online (Amazon, iHerb), direct-to-consumer.
- Food Processing – 35% of revenue. Functional foods (protein bars, beverages, yogurts), infant formula additives, sports nutrition ready-to-drink shakes.
Typical user case – sports nutrition brand: A leading sports nutrition brand (MyProtein/Optimum Nutrition) launches a “colostrum + whey” post-workout recovery powder (10g colostrum per serving, 30% IgG). Retail price: $50 for 500g ($100/kg). Cost of goods: skim colostrum powder $40/kg → $20 per unit (40% of retail price). Marketing claims: “immune support + muscle recovery.” Annual volume: 100 tons skim colostrum powder = $4M ingredient cost, $10M retail revenue.
Exclusive observation – bovine vs. caprine colostrum: Bovine colostrum dominates (>95% of market) due to scale (dairy industry). Caprine (goat) colostrum is a small but growing niche (5-10% premium price), marketed for “easier digestibility” and “hypoallergenic” claims. Production volume limited (goat dairy much smaller than cattle).
3. Regional Dynamics and Consumer Trends
| Region | Market Share (2025) | Key Drivers |
|---|---|---|
| North America | 35% | Largest supplement market, sports nutrition culture, gut health trend, aging population |
| Europe | 30% | Germany, UK, Netherlands leaders; functional foods, clinical nutrition |
| Asia-Pacific | 25% | Fastest-growing (7% CAGR), China (aging population, health awareness), Japan (longevity), India (emerging) |
| RoW | 10% | Australia, New Zealand (colostrum production), Brazil, Middle East |
Exclusive observation – pet supplement boom: Skim colostrum powder is increasingly used in premium pet supplements (dogs, cats, horses). Claims: “immune support,” “gut health,” “allergy relief,” “senior pet vitality.” Price premium: 2-3x human supplement prices on a per-serving basis. Growth rate: 15% CAGR, outpacing human colostrum market.
4. Competitive Landscape and Outlook
The skim colostrum powder market is moderately concentrated, with vertically integrated producers controlling raw material supply:
| Tier | Supplier | Key Strengths | Focus |
|---|---|---|---|
| 1 | Biostrum Nutraceutical (India) | Largest producer, cost leadership, global distribution | Mass market, standard grade (<30% IgG) |
| 1 | Immuno-Dynamic (US) | High-quality, clinical focus, cold-processed | Premium (30-40% IgG), medical foods |
| 2 | Colostrum BioTec (Germany) | European leader, organic certification, regulatory compliance | EU market, premium |
| 2 | BioNatIn (New Zealand) | Grass-fed, hormone-free, traceability | Premium export, Asian markets |
| 3 | Powerstrum Colostrum (US) | Small batch, direct-to-consumer | Niche, ultra-premium (>40% IgG) |
Technology roadmap (2027-2030):
- Fractionated colostrum components – Isolated IgG, lactoferrin, growth factors (IGF-1) for targeted clinical applications (higher margin than whole powder)
- Fermentation-derived colostrum bioactives – Recombinant lactoferrin and immunoglobulins (Perfect Day, others), vegan/animal-free, lower cost potential
- Clean label colostrum – No additives, non-GMO, grass-fed, organic certification increasingly important for premium positioning
With 4.9% CAGR and 18,000 tons sold in 2024 (projected 25,000+ tons by 2030), the skim colostrum powder market benefits from immune health trends (post-COVID), sports nutrition growth, aging population (gut health, sarcopenia prevention), and pet humanization trends. Risks include raw material seasonality (calving cycles), competition from plant-based immune supplements (elderberry, echinacea, zinc), and price sensitivity in mass-market supplements (consumers may trade down to whey or plant protein).
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
